Back to Search
Start Over
Supplementary Table 2 from Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Treatment-emergent adverse events (safety analysis set)
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1717f7013cb7b86fc4d1d2d54fe7d4f9
- Full Text :
- https://doi.org/10.1158/2159-8290.22535039